Inspire Medical Systems, Inc. Debt Securities, Available-for-sale, Amortized Cost
Inspire Medical Systems, Inc. (INSP) had Debt Securities, Available-for-sale, Amortized Cost of $75.05 million as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2019-05-07
- 2019-03-31: Debt Securities, Available-for-sale, Amortized Cost $75.05M.
- 2018-12-31: Debt Securities, Available-for-sale, Amortized Cost $90.97M.
- 2018-09-30: Debt Securities, Available-for-sale, Amortized Cost $94.14M.
- 2017-12-31: Debt Securities, Available-for-sale, Amortized Cost $7.19M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2019-03-31 | $75.05M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $90.97M 10-Q · filed 2019-05-07 |
| 2018-09-30 | $94.14M 10-Q · filed 2018-11-06 |
| 2017-12-31 | $7.19M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |